Abcam

Abcam Limited
Formerly
  • Abcam Limited (1998–2005)
  • Abcam plc (2005–2023)[1]
Company typeSubsidiary
Industry
Founded1998; 26 years ago (1998)
Founders
HeadquartersCambridge Biomedical Campus,
Cambridge
,
UK
Key people
Markus Lusser (president)
Products
RevenueIncrease £361.7 million (2022)[2]
Decrease £(10.1) million (2022)[2]
Decrease £(8.5) million (2022)[2]
Total assetsIncrease £1,057 million (2022)[2]
Total equityIncrease £726.9 million (2022)[2]
Number of employees
1,760 (2022)[2]
Parent
Website

Abcam Limited[1] is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in Research and Development (R&D). Abcam was listed on the Nasdaq[3] and the London Stock Exchange until it was acquired by Danaher Corporation in 2023.[4]

  1. ^ a b "Abcam Limited overview - Find and update company information - GOV.UK". Companies House. 12 February 1998. Retrieved 13 February 2024.
  2. ^ a b c d e f "Abcam 2022 Annual Report (Form 20-F)". US Securities and Exchange Commission. 20 March 2023. Retrieved 12 August 2023.
  3. ^ "ABCAM share price (ABCM) - Nasdaq".
  4. ^ "Danaher Completes $5.7B Acquisition of Abcam". Contract Pharma. 6 December 2023.